Tech Company Financing Transactions

Solace Pharmaceuticals Funding Round

On 3/31/2008, Solace Pharmaceuticals landed $6.7 million in investment from InterWest Partners and Polaris Partners.

Transaction Overview

Announced On
3/31/2008
Transaction Type
Venture Equity
Amount
$6,749,000
Round
Undisclosed
Investors

InterWest Partners (Christopher Ehrlich)

Polaris Partners (Kevin Bitterman)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
Four Cambridge Center 2nd floor
Cambridge, MA 02142
USA
Email Address
Overview
Solace was co-founded in March 2006 by PureTech Ventures and a preeminent team of scientific, clinical, regulatory and drug development experts who are collaborating to translate groundbreaking scientific discoveries in pain biology into innovative, effective therapeutic strategies for addressing chronic pain.
Profile
Solace Pharmaceuticals LinkedIn Company Profile
Social Media
Solace Pharmaceuticals Company Twitter Account
Company News
Solace Pharmaceuticals News
Facebook
Solace Pharmaceuticals on Facebook
YouTube
Solace Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Eliot Forster
  Eliot Forster LinkedIn Profile  Eliot Forster Twitter Account  Eliot Forster News  Eliot Forster on Facebook
Vice President
Alasdair Naylor
  Alasdair Naylor LinkedIn Profile  Alasdair Naylor Twitter Account  Alasdair Naylor News  Alasdair Naylor on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2008: Feder8 venture capital transaction
Next: 3/31/2008: F-Origin venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary